Search Results 771-780 of 21551 for Inhibition
* Previous treatment with a PKC inhibitor (including prior treatment with IDE196), an inhibitor directly targeting MET, or an inhibitor directly targeting GNAQ/ ...
- Individuals who previously received topoisomerase I inhibitors or antibody-drug conjugates containing a topoisomerase inhibitor. - High-dose systemic ...
Gastrointestinal stromal tumor (GIST). Displaying 20 studies. A Study of Ziftomenib, an Oral Menin Inhibitor, in Combination with Imatinib in Patients with ...
Not on inhaled or systemic steroids, proton pump inhibitors, H2 blockers or Leukotriene inhibitors; Adults and children without known history of ...
Prior treatment with any RAF inhibitor, MEK inhibitor, cetuximab, panitumumab or other EGFR inhibitors. Prior irinotecan hypersensitivity or toxicity that ...
Selective serotonin reuptake inhibitors (SSRIs) · Serotonin and norepinephrine reuptake inhibitors (SNRIs) · Sundowning: Late-day confusion · Treatment- ...
... inhibitors (prior iniparib, since it is no longer considered a PARP inhibitor, is allowed); Patients may not be receiving any other investigational agents ...
Calcineurin inhibitor ointments, such as tacrolimus (Protopic) or pimecrolimus (Elidel) might be effective for people with small areas of depigmentation ...
therapy, including a proteasome inhibitors (PI), an ... - Permitted to be venetoclax or BCL-2 inhibitor exposed in previous lines of therapy.
These are known as PDE5 inhibitors. Some supplements can cause side effects. They also can affect other medicines and health conditions. And the amount of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.